M. Sabloff

M. Perales, E. Guinan, S. Mineishi, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell Transplantation.

H. Atkins, D. Allan, L. Huebsch, 2016, JAMA neurology.

Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?

M. Perales, F. Appelbaum, J. Liesveld, 2013, Blood.

Can GCSF-stimulated donor lymphocyte infusions improve outcomes for relapsed disease following allogeneic hematopoietic cell transplantation? A systematic review and meta-analysis

D. Allan, C. Bredeson, M. Sabloff, 2022, Leukemia & lymphoma.

Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group.

J. Connors, K. Savage, T. Panzarella, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Total Body Irradiation for Hematopoietic Stem Cell Transplantation: What Can We Agree on?

M. Sabloff, R. Samant, S. Tisseverasinghe, 2021, Current oncology.

High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes

B. Leber, Houston, K. Yee, 2022 .

A 15-year analysis of early and late autologous hematopoietic stem cell transplant in relapsed, aggressive, transformed, and nontransformed follicular lymphoma.

H. Atkins, B. Hutton, D. Fergusson, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis

B. Sandmaier, M. Aljurf, R. Gale, 2016, Cancer.

Patient‐reported fatigue refines prognosis in higher‐risk myelodysplastic syndromes (MDS): a MDS‐CAN study

B. Leber, K. Yee, R. Buckstein, 2021, British journal of haematology.

Clinical Efficacy and Safety of Oral Decitabine/Cedazuridine in 133 Patients with Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)

B. Leber, H. Deeg, H. Kantarjian, 2020, Blood.

Vascular access devices in leukemia: a retrospective review amongst patients treated at The Ottawa Hospital with induction chemotherapy for acute leukemia

S. Doucette, L. Huebsch, S. Mcdiarmid, 2012, Leukemia & lymphoma.

Intermittent Transfusion Independence Is Associated with Improved Overall Survival in Patients with Transfusion Dependent MDS

B. Leber, R. Wells, K. Yee, 2019, Blood.

Total Body Irradiation without Chemotherapy as Conditioning for an Allogeneic Hematopoietic Cell Transplantation for Adult Acute Myeloid Leukemia

H. Atkins, D. Allan, L. Huebsch, 2016, Case reports in hematology.

HLA-matched sibling bone marrow transplantation for β-thalassemia major.

M. Chandy, R. Gale, A. Ghavamzadeh, 2011, Blood.

Nelarabine-containing regimen followed by daratumumab as an effective salvage therapy and bridge to allogeneic hematopoietic stem cell transplantation for primary refractory early T-cell precursor lymphoblastic leukemia

C. Bredeson, M. Sabloff, P. Berardi, 2021, Leukemia & lymphoma.

Outcomes of HLA Matched Sibling Donor Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia: Myeloablative vs. Reduced-Intensity Conditioning Regimens

J. Cortes, M. Aljurf, I. Lewis, 2014 .

The effect of plasmapheresis on the serum activity level of dalteparin: a case report

P. Wells, M. Sabloff, 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Outcomes Associated with Reducing the Urine Alkalinization Threshold in Patients Receiving High‐Dose Methotrexate

S. Kanji, M. Sabloff, P. Giguère, 2017, Pharmacotherapy.

A retrospective comparison of conventional intensity conditioning and reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in myelofibrosis

B. Leber, N. Kröger, J. Lipton, 2009, Bone Marrow Transplantation.

Use of recombinant-hirudin in pulmonary thromboendarterectomy.

P. Wells, F. Rubens, M. Bourke, 2000, The Annals of thoracic surgery.

B. Leber, R. Wells, K. Yee, 2014 .

Contaminating tumour cells in autologous PBSC grafts do not influence survival or relapse following transplant for multiple myeloma or B-cell non-Hodgkin's lymphoma

H. Atkins, D. Allan, L. Huebsch, 2009, Bone Marrow Transplantation.

A Quality Initiative of the Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario) Minimal Residual Disease Testing in Acute Leukemia

H. Feilotter, A. Pollett, A. Schuh, 2020 .

Treatment of older patients with acute myeloid leukemia (AML): a Canadian consensus.

B. Leber, J. Ashkenas, J. Brandwein, 2013, American journal of blood research.

Acute promyelocytic leukaemia is characterized by stable incidence and improved survival that is restricted to patients managed in leukaemia referral centres: a pan‐Canadian epidemiological study

J. Bergeron, D. Turner, David Jones, 2014, British journal of haematology.

Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission.

Alan M. Miller, R. Vij, F. Baron, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors

M. Aljurf, R. Gale, J. Passweg, 2010, Haematologica.

Evaluating dose-limiting toxicities of MDM2 inhibitors in patients with solid organ and hematologic malignancies: A systematic review of the literature.

H. Atkins, T. Ramsay, C. Bredeson, 2019, Leukemia research.

Anti-cruciform DNA affinity purification of active mammalian origins of replication.

M. Zannis‐Hadjopoulos, G. Price, M. Sabloff, 1991, Biochimica et biophysica acta.

Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma

H. Atkins, L. Huebsch, S. Mcdiarmid, 2006, Annals of Hematology.

Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis.

J. Dipersio, M. Tallman, R. Gale, 2010, Blood.

Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation

H. Atkins, D. Allan, L. Huebsch, 2015, Transfusion.

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States.

W. Wood, M. Sorror, F. Baron, 2017, Blood.

Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia.

B. George, R. Gale, H. Lazarus, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Overall survival in lower IPSS risk MDS by receipt of iron chelation therapy, adjusting for patient‐related factors and measuring from time of first red blood cell transfusion dependence: an MDS‐CAN analysis

B. Leber, R. Wells, K. Yee, 2017, British journal of haematology.

Pharmacokinetic Exposure Equivalence and Preliminary Efficacy and Safety from a Randomized Cross over Phase 3 Study (ASCERTAIN study) of an Oral Hypomethylating Agent ASTX727 (cedazuridine/decitabine) Compared to IV Decitabine

H. Deeg, G. Garcia-Manero, K. Yee, 2019, Blood.

Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.

H. Atkins, D. Allan, L. Huebsch, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers

D. Allan, L. Huebsch, S. Mcdiarmid, 2018, Blood Cancer Journal.

Hematopoietic Recovery and Overall Survival after HLA-Matched Sibling Transplants for Older Patients with Severe Aplastic Anemia (SAA).

M. Aljurf, R. Gale, J. Passweg, 2008 .

HLA-matched sibling bone marrow transplantation for (cid:1) -thalassemia major

M. Chandy, R. Gale, A. Ghavamzadeh, 2011 .

Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial

D. Arnold, H. Atkins, A. Bar-Or, 2016, The Lancet.

Effect of Donor Age and Donor Relatedness on Time to Allogeneic Hematopoietic Cell Transplantation in Acute Leukemia.

H. Atkins, D. Allan, L. Huebsch, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes of human leukocyte antigen-matched sibling donor hematopoietic cell transplantation in chronic lymphocytic leukemia: myeloablative versus reduced-intensity conditioning regimens.

J. Cortes, M. Aljurf, I. Lewis, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma.

J. Connors, K. Savage, T. Panzarella, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.

J. Cortes, M. Aljurf, M. Tallman, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.

J. Cortes, M. Aljurf, J. Szer, 2013, Blood.

Does total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia?

J. Cortes, M. Aljurf, I. Lewis, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

with TBI following cyclophosphamide in combination with busulfan compared Better leukemia-free and overall survival in AML in first remission

J. Cortes, M. Aljurf, J. Szer, 2013 .

The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission.

J. Szer, B. George, M. Tallman, 2010, Blood.

High Rates of Transplantation in the Phase III Sierra Trial Utilizing Anti-CD45 (Iodine) 131I-Apamistamab (Iomab-B) Conditioning with Successful Engraftment and Tolerability in Relapsed Refractory (R/R) Acute Myeloid Leukemia (AML) Patients after Lack of Response to Conventional Care and Targeted Th

M. Berger, P. Hari, K. van Besien, 2022, Transplantation and Cellular Therapy.

Clinical Experience in the Randomized Phase 3 Sierra Trial: Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] Conditioning Enables Hematopoietic Cell Transplantation with Successful Engraftment and Acceptable Safety in Patients with Active, Relapsed/Refractory AML Not Responding to Targeted Therapies

M. Berger, P. Hari, J. Pagel, 2021, Blood.

J. Sierra, M. Tallman, R. Gale, 2008, Blood.

Systemic mastocytosis emerging after azacitidine treatment of refractory anaemia with excess blasts type 2

C. Bredeson, D. Sheppard, M. Sabloff, 2014, British Journal of Haematology.

Adipogenic Mesenchymal Stromal Cells from Bone Marrow and Their Hematopoietic Supportive Role: Towards Understanding the Permissive Marrow Microenvironment in Acute Myeloid Leukemia

R. B. Richardson, D. Allan, M. Brand, 2016, Stem Cell Reviews and Reports.

B. Leber, K. Rockwood, R. Wells, 2016, British journal of haematology.

Rapid Decrease in KRT14 and TP53 mRNA Expression in the Buccal Mucosa of Patients Receiving Total-Body Irradiation for Allogeneic Stem Cell Transplantation

H. Atkins, B. McKay, M. Sabloff, 2017, Radiation Research.

lymphoblastic leukemia in first complete remission Unrelated donor transplants in adults with Philadelphia-negative acute

J. Sierra, R. Gale, M. Bishop, 2011 .

Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study

E. Atenafu, C. Bredeson, J. Finke, 2016, Bone Marrow Transplantation.

Total body irradiation (18 Gy) without chemotherapy as conditioning for allogeneic hematopoietic cell transplantation in refractory acute myeloid leukemia

H. Atkins, D. Allan, T. Ramsay, 2020, Bone Marrow Transplantation.

Selecting the optimal targeted therapy for relapsed B-acute lymphoblastic leukemia

E. Leung, C. Bredeson, M. Sabloff, 2020, Leukemia & lymphoma.

Oral Decitabine/Cedazuridine in Patients with Lower Risk Myelodysplastic Syndrome: A Longer-Term Follow-up of from the Ascertain Study

B. Leber, H. Deeg, H. Kantarjian, 2021, Blood.

An MDS-specific frailty index based on cumulative deficits adds independent prognostic information to clinical prognostic scoring

B. Leber, K. Rockwood, R. Wells, 2019, Leukemia.

Impact of Frailty on Health Care Resource Utilization and Costs of Care in Myelodysplastic Syndromes

Y. Liu, B. Leber, C. Earle, 2023, JCO oncology practice.

Comparison of Allogeneic Hematopoietic Cell Transplantation Outcomes from Younger Matched Unrelated Donor Versus Older Sibling Donor for Acute Myeloid Leukemia

D. Allan, C. Bredeson, W. Saber, 2022, Blood.

Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy.

Adrian T. Grzybowski, T. Perkins, F. Dilworth, 2018, Cancer discovery.

The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes

Y. Liu, B. Leber, C. Earle, 2021, Annals of Hematology.

Evaluation of an Outpatient Model for Treatment of Acute Myeloid Leukemia

H. Atkins, D. Allan, T. Ramsay, 2016 .

Prolonged Survival in Bi-Allelic TP53-Mutated (TP53mut) MDS Subjects Treated with Oral Decitabine/Cedazuridine in the Ascertain Trial (ASTX727-02)

B. Leber, G. Garcia-Manero, K. Yee, 2022, Blood.

Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid Leukemia.

C. Hourigan, M. Aljurf, C. Bredeson, 2023, Transplantation and cellular therapy.

Serial assessment of toxicity after hematopoietic SCT can discern kinetics of transplant-related organ injury and patterns of recovery

H. Atkins, D. Allan, L. Huebsch, 2012, Bone Marrow Transplantation.

Younger Matched Unrelated Donors Confer Decreased Relapse Compared to Older Sibling Donors in Older B-cell ALL Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.

C. Hourigan, C. Bredeson, D. Marks, 2023, Transplantation and cellular therapy.

Efficacy of Oral Decitabine/Cedazuridine (ASTX727) in the CMML Subgroup from the Ascertain Phase 3 Study

B. Leber, H. Deeg, H. Kantarjian, 2021, Blood.

Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers

D. Allan, L. Huebsch, S. Mcdiarmid, 2018, Blood Cancer Journal.

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts.

R. Greil, H. Döhner, M. Minden, 2015, Blood.

Trial in Progress: Feasibility and Validation Study of the LSC17 Score in Acute Myeloid Leukemia Patients

B. Leber, M. Minden, Steven M. Chan, 2019, Blood.

Breaking the Age Barrier: Physicians' Perceptions on Candidacy for Allogeneic Hematopoietic Cell Transplantation in Older Adults.

W. Wood, M. Sorror, D. Howard, 2021, Transplantation and cellular therapy.

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.

J. Cortes, M. Aljurf, J. Szer, 2013, Blood.

High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes

B. Leber, K. Yee, R. Buckstein, 2022, Haematologica.

Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.

M. Norkin, R. Vij, W. Wood, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

B. Leber, K. Rockwood, R. Wells, 2016, British journal of haematology.

Iron Chelation Is Associated with Improved Survival Adjusting for Disease and Patient Related Characteristics in Low/Int-1 Risk MDS at the Time of First Transfusion Dependence: A MDS-CAN Study

B. Leber, R. Wells, K. Yee, 2015 .

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.

R. Vij, W. Wood, J. Cortes, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?

M. Perales, A. Alousi, R. Champlin, 2013, Blood.